Sanket Patke
Sanket Patke
Verified email at bms.com
Title
Cited by
Cited by
Year
The design of polyvalent scaffolds for targeted delivery
D Vance, J Martin, S Patke, RS Kane
Advanced drug delivery reviews 61 (11), 931-939, 2009
552009
Pathogenic serum amyloid A 1.1 shows a long oligomer-rich fibrillation lag phase contrary to the highly amyloidogenic non-pathogenic SAA2. 2
S Srinivasan, S Patke, Y Wang, Z Ye, J Litt, SK Srivastava, MM Lopez, ...
Journal of Biological Chemistry 288 (4), 2744-2755, 2013
392013
Biomineralized anisotropic gold microplate–macrophage interactions reveal frustrated phagocytosis-like phenomenon: a novel paclitaxel drug delivery vehicle
AV Singh, M Batuwangala, R Mundra, K Mehta, S Patke, E Falletta, R Patil, ...
ACS applied materials & interfaces 6 (16), 14679-14689, 2014
352014
Characterization of the oligomerization and aggregation of human serum amyloid A
S Patke, S Srinivasan, R Maheshwari, SK Srivastava, JJ Aguilera, ...
PloS one 8 (6), e64974, 2013
232013
Design of Monodisperse and Well‐Defined Polypeptide‐Based Polyvalent Inhibitors of Anthrax Toxin
S Patke, M Boggara, R Maheshwari, SK Srivastava, M Arha, M Douaisi, ...
Angewandte Chemie International Edition 53 (31), 8037-8040, 2014
152014
Influence of the carboxy terminus of serum amyloid A on protein oligomerization, misfolding, and fibril formation
S Patke, R Maheshwari, J Litt, S Srinivasan, JJ Aguilera, W Colón, ...
Biochemistry 51 (14), 3092-3099, 2012
122012
bisFabs: Tools for rapidly screening hybridoma IgGs for their activities as bispecific antibodies
S Patke, J Li, P Wang, D Slaga, J Johnston, S Bhakta, S Panowski, ...
MAbs 9 (3), 430-437, 2017
62017
Current Status of Analytical Techniques for Characterization of Protein Stability
S Patke, J Stillahn, M Manning
Biopharma Asia 7 (1), 18-28, 2018
2018
Developing approaches to control stem cell fate using optogenetics and multivalency
R Kane, L Bugaj, T Vazin, R Ashton, A Conway, N Rode, A Choksi, ...
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 247, 2014
2014
Structural and kinetic differences in oligomerization-fibrillation of serum amyloid A and not the intrinsic amyloidogenicity may contribute to pathogenesis in AA amyloidosis
S Srinivasan, S Patke, JJ Aguilera, RS Kane, W Colon
The FASEB Journal 27 (1_supplement), 996.11-996.11, 2013
2013
Oligomeric proteins: Toxicity, aggregation, and polyvalent inhibition
S Patke
Rensselaer Polytechnic Institute, 2013
2013
The system can't perform the operation now. Try again later.
Articles 1–11